Association Between Buprenorphine Treatment Gaps, Opioid Overdose, and Health Care Spending in US Medicare Beneficiaries With Opioid Use Disorder

Original research
by
Gibbons, Jason B. et al

Release Date

2022

Geography

USA

Language of Resource

English

Full Text Available

No

Open Access / OK to Reproduce

No

Peer Reviewed

Yes

Objective

To estimate the association between buprenorphine treatment gaps, opioid overdose, and health care spending.

Findings/Key points

Medicare patients treated with buprenorphine between 2010 and 2017 had a lower associated opioid overdose risk and spending during treatment months than treatment gap months.

Design/methods

Longitudinal case-control study

Keywords

Overdose
Substitution/OAT
About PWUD